These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2738877)

  • 21. Iron(III)-adriamycin and Iron(III)-daunorubicin complexes: physicochemical characteristics, interaction with DNA, and antitumor activity.
    Beraldo H; Garnier-Suillerot A; Tosi L; Lavelle F
    Biochemistry; 1985 Jan; 24(2):284-9. PubMed ID: 2983753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The essential role of anthraquinones as substrates for NADH dehydrogenase in their redox cycling activity.
    Tarasiuk J; Garnier-Suillerot A; Stefańska B; Borowski E
    Anticancer Drug Des; 1992 Aug; 7(4):329-40. PubMed ID: 1324690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiglioma activity of GoPI-sugar, a novel gold(I)-phosphole inhibitor: chemical synthesis, mechanistic studies, and effectiveness in vivo.
    Jortzik E; Farhadi M; Ahmadi R; Tóth K; Lohr J; Helmke BM; Kehr S; Unterberg A; Ott I; Gust R; Deborde V; Davioud-Charvet E; Réau R; Becker K; Herold-Mende C
    Biochim Biophys Acta; 2014 Aug; 1844(8):1415-26. PubMed ID: 24440405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Variations on the Theme of Gold(III) C
    Carboni S; Zucca A; Stoccoro S; Maiore L; Arca M; Ortu F; Artner C; Keppler BK; Meier-Menches SM; Casini A; Cinellu MA
    Inorg Chem; 2018 Dec; 57(23):14852-14865. PubMed ID: 30457328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective killing of tumor cells in vitro by immunotoxin composed of antitumor antibiotic streptonigrin and polyclonal specific antibodies.
    Komissarenko SV; Penezina OP; Fomovskaya GN; Tolstikov VV; Preobrazhenskaya MN
    Int J Immunopharmacol; 1994 Dec; 16(12):1053-8. PubMed ID: 7705967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties.
    Rubbiani R; Kitanovic I; Alborzinia H; Can S; Kitanovic A; Onambele LA; Stefanopoulou M; Geldmacher Y; Sheldrick WS; Wolber G; Prokop A; Wölfl S; Ott I
    J Med Chem; 2010 Dec; 53(24):8608-18. PubMed ID: 21082862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and characterization of azolate gold(I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents.
    Galassi R; Burini A; Ricci S; Pellei M; Rigobello MP; Citta A; Dolmella A; Gandin V; Marzano C
    Dalton Trans; 2012 May; 41(17):5307-18. PubMed ID: 22391922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of Hydrophilic Gold(I) N-Heterocyclic Carbene (NHC) Complexes as Potent TrxR Inhibitors Using Biochemical and Mass Spectrometric Approaches.
    Karaca Ö; Scalcon V; Meier-Menches SM; Bonsignore R; Brouwer JMJL; Tonolo F; Folda A; Rigobello MP; Kühn FE; Casini A
    Inorg Chem; 2017 Nov; 56(22):14237-14250. PubMed ID: 29095609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Streptonigrin and lavendamycin partial structures. Probes for the minimum, potent pharmacophore of streptonigrin, lavendamycin, and synthetic quinoline-5,8-diones.
    Boger DL; Yasuda M; Mitscher LA; Drake SD; Kitos PA; Thompson SC
    J Med Chem; 1987 Oct; 30(10):1918-28. PubMed ID: 3656364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the C^N^C theme: Synthesis and biological properties of tridentate cyclometalated gold(III) complexes.
    Jürgens S; Scalcon V; Estrada-Ortiz N; Folda A; Tonolo F; Jandl C; Browne DL; Rigobello MP; Kühn FE; Casini A
    Bioorg Med Chem; 2017 Oct; 25(20):5452-5460. PubMed ID: 28823538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gold(I) carbene complexes causing thioredoxin 1 and thioredoxin 2 oxidation as potential anticancer agents.
    Schuh E; Pflüger C; Citta A; Folda A; Rigobello MP; Bindoli A; Casini A; Mohr F
    J Med Chem; 2012 Jun; 55(11):5518-28. PubMed ID: 22621714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mechanism of the degradation of DNA by streptonigrin.
    Cone R; Hasan SK; Lown JW; Morgan AR
    Can J Biochem; 1976 Mar; 54(3):219-23. PubMed ID: 1260505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical effects of the methyl ester of streptonigrin.
    Kremer WB; Laszlo J
    Biochem Pharmacol; 1966 Aug; 15(8):1111-8. PubMed ID: 4382149
    [No Abstract]   [Full Text] [Related]  

  • 34. Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases.
    Beall HD; Mulcahy RT; Siegel D; Traver RD; Gibson NW; Ross D
    Cancer Res; 1994 Jun; 54(12):3196-201. PubMed ID: 8205540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions.
    Rigobello MP; Messori L; Marcon G; Agostina Cinellu M; Bragadin M; Folda A; Scutari G; Bindoli A
    J Inorg Biochem; 2004 Oct; 98(10):1634-41. PubMed ID: 15458826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrocatalytic oxidation of NADH at gold nanoparticles loaded poly(3,4-ethylenedioxythiophene)-poly(styrene sulfonic acid) film modified electrode and integration of alcohol dehydrogenase for alcohol sensing.
    Manesh KM; Santhosh P; Gopalan A; Lee KP
    Talanta; 2008 Jun; 75(5):1307-14. PubMed ID: 18585217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organo-soluble chiral thiol-monolayer-protected gold nanorods.
    Li Y; Yu D; Dai L; Urbas A; Li Q
    Langmuir; 2011 Jan; 27(1):98-103. PubMed ID: 21142010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutathione reductase from yeast. Differential reactivity of the nascent thiols in two-electron reduced enzyme and properties of a monoalkylated derivative.
    Arscott LD; Thorpe C; Williams CH
    Biochemistry; 1981 Mar; 20(6):1513-20. PubMed ID: 7013796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FAD analogues as prosthetic groups of human glutathione reductase. Properties of the modified enzyme species and comparisons with the active site structure.
    Krauth-Siegel RL; Schirmer RH; Ghisla S
    Eur J Biochem; 1985 Apr; 148(2):335-44. PubMed ID: 3987692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Organothallium(III) reagents for modification of biomacromolecules: irreversible labelling of phosphoglycerate kinase from rabbit muscle.
    Bunni MA; Baindur SR; Douglas KT; Drake AF
    Biochim Biophys Acta; 1987 Mar; 923(3):421-30. PubMed ID: 3828383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.